Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Champions Oncology - 37 Year Stock Price History | CSBR

Historical daily share price chart and data for Champions Oncology since 1988 adjusted for splits and dividends. The latest closing stock price for Champions Oncology as of April 21, 2025 is 7.92.
  • The all-time high Champions Oncology stock closing price was 94.80 on August 24, 1990.
  • The Champions Oncology 52-week high stock price is 11.99, which is 51.4% above the current share price.
  • The Champions Oncology 52-week low stock price is 3.60, which is 54.5% below the current share price.
  • The average Champions Oncology stock price for the last 52 weeks is 6.31.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Champions Oncology Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 9.7399 8.2000 11.7000 7.3400 7.9200 -7.58%
2024 5.1026 5.7900 8.6200 3.7900 8.5700 52.49%
2023 5.3383 4.4200 7.3200 4.0000 5.6199 24.61%
2022 7.6402 8.4800 9.4700 3.7500 4.5100 -46.05%
2021 10.2666 10.8000 13.7500 7.7600 8.3600 -22.52%
2020 8.6969 8.1400 13.2700 4.1900 10.7900 29.53%
2019 7.8199 7.8900 12.2300 5.1200 8.3300 6.66%
2018 7.2503 4.0200 17.4700 3.3910 7.8100 101.29%
2017 3.1827 2.8500 4.7500 2.3301 3.8800 53.36%
2016 2.4928 3.7800 4.1000 1.4800 2.5300 -29.13%
2015 5.9670 6.1188 9.0000 2.7600 3.5700 -40.49%
2014 10.4494 14.4000 14.8800 4.4400 5.9988 -58.34%
2013 11.5388 3.0000 22.8000 3.0000 14.4000 300.00%
2012 6.1134 9.0000 9.0000 3.0000 3.6000 -60.00%
2011 10.4591 10.8000 14.4000 5.4000 9.0000 -16.67%
2010 10.5415 9.3600 13.2000 7.8480 10.8000 12.50%
2009 10.7948 12.9600 15.0000 6.6000 9.6000 -25.93%
2008 11.3856 16.2000 19.2000 3.9600 12.9600 -22.86%
2007 8.5479 0.4800 25.2000 0.3750 16.8000 3400.00%
2006 0.3404 0.6000 1.2000 0.1380 0.4800 -36.00%
2005 0.5256 0.5625 0.9600 0.2400 0.7500 33.33%
2004 0.4098 0.1800 0.8400 0.1800 0.5625 134.38%
2003 0.2003 0.1800 0.4800 0.0720 0.2400 33.33%
2002 0.4544 1.0800 1.2000 0.1800 0.1800 -75.00%
2001 1.2119 2.1600 2.5200 0.6000 0.7200 -69.23%
2000 2.1096 0.9600 6.3600 0.8400 2.3400 143.75%
1999 1.0298 0.8400 1.8000 0.7200 0.9600 14.29%
1998 2.8371 3.3750 5.6250 0.8400 0.8400 -81.33%
1997 6.5787 3.7500 9.3750 3.3750 4.5000 33.33%
1996 2.3420 0.7500 6.7500 0.7500 3.3750 301.79%
1995 1.0730 0.4800 2.0400 0.4800 0.8400 -62.67%
1994 3.6799 3.3750 6.7500 1.5000 2.2500 -40.00%
1993 11.5512 10.8750 28.5000 3.0000 3.7500 -61.54%
1992 23.6610 32.2500 35.2500 7.5000 9.7500 -69.77%
1991 52.9845 56.2500 56.2500 28.5000 32.2500 -42.67%
1990 58.6351 56.2500 94.8000 56.2500 56.2500 0.00%
1989 56.2500 56.2500 56.2500 56.2500 56.2500 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.110B $0.050B
Champions Oncology, Inc., formerly known as Champions Biotechnology, Inc., engages in the development of advanced technology solutions to personalize the development and use of oncology drugs. The Company's Tumorgraft Technology Platform is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune deficient mice followed by propagation of the resulting engraftments. This technology can evaluate tumor sensitivity/resistance to various single, combination standard and novel chemotherapy agents. Champions Oncology, Inc. is based in Baltimore, Maryland.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $95.045B 37.51
Zoetis (ZTS) United States $66.334B 25.11
Takeda Pharmaceutical (TAK) Japan $46.806B 10.36
Daiichi Sankyo, - (DSNKY) Japan $41.678B 25.40
Summit Therapeutics (SMMT) United States $18.154B 0.00
Sandoz Group AG (SDZNY) Switzerland $17.706B 0.00
Merck (MKKGY) Germany $17.202B 14.23
Astellas Pharma (ALPMY) Japan $16.920B 11.99
Shionogi (SGIOY) Japan $14.087B 0.00
United Therapeutics (UTHR) United States $12.788B 11.57
Neurocrine Biosciences (NBIX) United States $10.030B 30.82
IPSEN (IPSEY) France $8.640B 0.00
Orion OYJ (ORINY) Finland $7.957B 22.55
Madrigal Pharmaceuticals (MDGL) United States $6.661B 0.00
Stevanato Group S.p.A (STVN) Italy $6.620B 42.04
Corcept Therapeutics (CORT) United States $6.567B 50.19
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.813B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.547B 11.36
Grifols, S.A (GRFS) Spain $4.868B 0.00
Ionis Pharmaceuticals (IONS) United States $4.515B 0.00
Soleno Therapeutics (SLNO) United States $3.209B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.831B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.747B 11.15
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.281B 14.15
Recursion Pharmaceuticals (RXRX) United States $2.211B 0.00
Hypermarcas (HYPMY) Brazil $2.128B 8.40
NewAmsterdam Pharma (NAMS) Netherlands $1.794B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.638B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.546B 0.00
Guardian Pharmacy Services (GRDN) United States $1.526B 0.00
ARS Pharmaceuticals (SPRY) United States $1.460B 186.00
Evotec AG (EVO) Germany $1.278B 0.00
Indivior (INDV) United States $1.242B 5.40
Ocular Therapeutix (OCUL) United States $1.162B 0.00
Ardelyx (ARDX) United States $1.148B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.064B 43.06
Dyne Therapeutics (DYN) United States $0.928B 0.00
AleAnna (ANNA) United States $0.878B 0.00
Collegium Pharmaceutical (COLL) United States $0.868B 4.61
Harrow (HROW) United States $0.855B 0.00
Enliven Therapeutics (ELVN) United States $0.810B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.776B 0.00
Xencor (XNCR) United States $0.683B 0.00
Cronos Group (CRON) Canada $0.682B 0.00
Bioventus (BVS) United States $0.641B 16.64
Xeris Biopharma Holdings (XERS) United States $0.633B 0.00
KalVista Pharmaceuticals (KALV) United States $0.597B 0.00
Organogenesis (ORGO) United States $0.535B 0.00
Savara (SVRA) United States $0.520B 0.00
Akebia Therapeutics (AKBA) United States $0.487B 0.00
Relay Therapeutics (RLAY) United States $0.456B 0.00
Elite Pharmaceuticals (ELTP) United States $0.450B 0.00
USANA Health Sciences (USNA) United States $0.448B 9.13
Theravance Biopharma (TBPH) Cayman Islands $0.431B 0.00
Siga Technologies (SIGA) United States $0.428B 7.30
Tourmaline Bio (TRML) United States $0.411B 0.00
Verve Therapeutics (VERV) United States $0.408B 0.00
Zevra Therapeutics (ZVRA) United States $0.387B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.353B 0.00
Altimmune (ALT) United States $0.350B 0.00
Oruka Therapeutics (ORKA) United States $0.345B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.301B 17.93
Heron Therapeutics (HRTX) United States $0.280B 0.00
CytoDyn (CYDY) United States $0.251B 0.00
Aquestive Therapeutics (AQST) United States $0.248B 0.00
Avita Medical (RCEL) United States $0.243B 0.00
ProKidney (PROK) United States $0.231B 0.00
OmniAb (OABI) United States $0.219B 0.00
Nature's Sunshine Products (NATR) United States $0.218B 25.70
Esperion Therapeutics (ESPR) United States $0.188B 23.75
MediWound (MDWD) Israel $0.185B 0.00
Wellgistics Health (WGRX) United States $0.171B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.164B 0.00
Nanobiotix S.A (NBTX) France $0.155B 0.00
Journey Medical (DERM) United States $0.144B 0.00
Profound Medical (PROF) Canada $0.144B 0.00
Protara Therapeutics (TARA) United States $0.143B 0.00
4D Molecular Therapeutics (FDMT) United States $0.142B 0.00
Inhibikase Therapeutics (IKT) United States $0.141B 0.00
Regulus Therapeutics (RGLS) United States $0.136B 0.00
Aldeyra Therapeutics (ALDX) United States $0.131B 0.00
Korro Bio (KRRO) United States $0.131B 0.00
Lyell Immunopharma (LYEL) United States $0.128B 0.00
Aclaris Therapeutics (ACRS) United States $0.123B 0.00
Larimar Therapeutics (LRMR) United States $0.122B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Nektar Therapeutics (NKTR) United States $0.118B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.118B 36.33
Enanta Pharmaceuticals (ENTA) United States $0.109B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.101B 0.00
OptiNose (OPTN) United States $0.093B 0.00
Lexeo Therapeutics (LXEO) United States $0.090B 0.00
Galectin Therapeutics (GALT) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.084B 0.00
Cardiol Therapeutics (CRDL) Canada $0.083B 0.00
ESSA Pharma (EPIX) Canada $0.079B 0.00
VAXART, INC (VXRT) United States $0.078B 0.00
Context Therapeutics (CNTX) United States $0.076B 0.00
Telomir Pharmaceuticals (TELO) United States $0.074B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.074B 0.00
Unicycive Therapeutics (UNCY) United States $0.072B 0.00
Cassava Sciences (SAVA) United States $0.070B 0.00
Achieve Life Sciences (ACHV) Canada $0.069B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.066B 0.00
Vivani Medical (VANI) United States $0.063B 0.00
Fractyl Health (GUTS) United States $0.060B 0.00
Pyxis Oncology (PYXS) United States $0.059B 0.00
Assertio Holdings (ASRT) United States $0.058B 0.00
Metagenomi (MGX) United States $0.057B 0.00
Acrivon Therapeutics (ACRV) United States $0.057B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.056B 0.00
Nutriband (NTRB) United States $0.056B 0.00
Inotiv (NOTV) United States $0.055B 0.00
PMV Pharmaceuticals (PMVP) United States $0.053B 0.00
Gain Therapeutics (GANX) United States $0.050B 0.00
Avalo Therapeutics (AVTX) United States $0.047B 0.00
Century Therapeutics (IPSC) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.047B 0.00
Prelude Therapeutics (PRLD) United States $0.046B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.045B 0.00
Dominari Holdings (DOMH) United States $0.044B 0.00
ElectroCore (ECOR) United States $0.043B 0.00
Karyopharm Therapeutics (KPTI) United States $0.042B 0.00
Rafael Holdings (RFL) United States $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.037B 0.00
SCYNEXIS (SCYX) United States $0.035B 0.00
NRx Pharmaceuticals (NRXP) United States $0.033B 0.00
Surrozen (SRZN) United States $0.032B 0.00
FibroGen (FGEN) United States $0.029B 0.00
VYNE Therapeutics (VYNE) United States $0.028B 0.00
PolyPid (PYPD) Israel $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
CASI Pharmaceuticals (CASI) China $0.024B 0.00
DURECT (DRRX) United States $0.023B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
Enlivex Therapeutics (ENLV) Israel $0.018B 0.00
Mannatech (MTEX) United States $0.018B 7.14
Natural Alternatives (NAII) United States $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
BioVie (BIVI) United States $0.016B 0.00
GlycoMimetics (GLYC) United States $0.014B 0.00
Mangoceuticals (MGRX) United States $0.013B 0.00
MEI Pharma (MEIP) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.012B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Plus Therapeutics (PSTV) United States $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.011B 8.42
Scienture Holdings (SCNX) United States $0.011B 0.00
Incannex Healthcare (IXHL) Australia $0.011B 0.00
Traws Pharma (TRAW) United States $0.010B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
Relmada Therapeutics (RLMD) United States $0.010B 0.00
BioLineRx (BLRX) Israel $0.010B 0.00
Cosmos Health (COSM) United States $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 2.68
Nuvilex (PMCB) United States $0.008B 0.00
Talphera (TLPH) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Petros Pharmaceuticals (PTPI) United States $0.002B 0.00
CERo Therapeutics Holdings (CERO) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00